Pedro C. Lirio
Ribeirao Preto, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex.
Journal: Neuropharmacology
Published: January 12, 2026
Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 11, 2025
Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium Valproate.
Journal: Autism research : official journal of the International Society for Autism Research
Published: May 20, 2025
Predictors of functional recovery in the first year after severe traumatic brain injury.
Journal: Brazilian journal of physical therapy
Published: October 23, 2024
Cannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders.
Journal: International review of neurobiology
Published: July 19, 2024
A novel weight-drop closed head focal traumatic brain injury: A candidate to translational studies?
Journal: MethodsX
Published: May 10, 2024
Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19.
Journal: Brain, behavior, & immunity - health
Published: January 23, 2024
Would frontal midline theta indicate cognitive changes induced by non-invasive brain stimulation? A mini review.
Journal: Frontiers in human neuroscience
Published: December 05, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026